Literature DB >> 32580944

Negatively charged amino acids in the stalk region of membrane proteins reduce ectodomain shedding.

Ryo Iwagishi1, Rika Tanaka1, Munenosuke Seto1, Tomoyo Takagi1, Naoko Norioka2, Tomoe Ueyama1,3, Teruhisa Kawamura1,3, Junichi Takagi2, Yoshihiro Ogawa4,5,6, Kyoko Shirakabe7,3,4.   

Abstract

Ectodomain shedding is a post-translational modification mechanism by which the entire extracellular domain of membrane proteins is liberated through juxtamembrane processing. Because shedding rapidly and irreversibly alters the characteristics of cells, this process is properly regulated. However, the molecular mechanisms governing the propensity of membrane proteins to shedding are largely unknown. Here, we present evidence that negatively charged amino acids within the stalk region, an unstructured juxtamembrane region at which shedding occurs, contribute to shedding susceptibility. We show that two activated leukocyte cell adhesion molecule (ALCAM) protein variants produced by alternative splicing have different susceptibilities to ADAM metallopeptidase domain 17 (ADAM17)-mediated shedding. Of note, the inclusion of a stalk region encoded by a 39-bp-long alternative exon conferred shedding resistance. We found that this alternative exon encodes a large proportion of negatively charged amino acids, which we demonstrate are indispensable for conferring the shedding resistance. We also show that the introduction of negatively charged amino acids into the stalk region of shedding-susceptible ALCAM variant protein attenuates its shedding. Furthermore, we observed that negatively charged amino acids residing in the stalk region of Erb-B2 receptor tyrosine kinase 4 (ERBB4) are indispensable for its shedding resistance. Collectively, our results indicate that negatively charged amino acids within the stalk region interfere with the shedding of multiple membrane proteins. We conclude that the composition of the stalk region determines the shedding susceptibility of membrane proteins.
© 2020 Iwagishi et al.

Entities:  

Keywords:  ADAM; Erb-B2 receptor tyrosine kinase 4 (ERBB4); activated leukocyte cell adhesion molecule (ALCAM); alternative splicing; ectodomain shedding; immunoglobulin-like domain; membrane protein; metalloprotease; posttranslational modification; stalk region

Mesh:

Substances:

Year:  2020        PMID: 32580944      PMCID: PMC7458810          DOI: 10.1074/jbc.RA120.013758

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Ectodomain cleavage of ErbB-4: characterization of the cleavage site and m80 fragment.

Authors:  Qiu-Chen Cheng; Oleg Tikhomirov; Wenli Zhou; Graham Carpenter
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

2.  VIP36 protein is a target of ectodomain shedding and regulates phagocytosis in macrophage Raw 264.7 cells.

Authors:  Kyoko Shirakabe; Seisuke Hattori; Motoharu Seiki; Shigeo Koyasu; Yasunori Okada
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

3.  Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.

Authors:  Aukje W Zimmerman; Ben Joosten; Ruurd Torensma; Jane R Parnes; Frank N van Leeuwen; Carl G Figdor
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

4.  A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester.

Authors:  K Elenius; G Corfas; S Paul; C J Choi; C Rio; G D Plowman; M Klagsbrun
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

5.  Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10.

Authors:  Cristina I Caescu; Grace R Jeschke; Benjamin E Turk
Journal:  Biochem J       Date:  2009-10-23       Impact factor: 3.857

6.  A matrix metalloproteinase expressed on the surface of invasive tumour cells.

Authors:  H Sato; T Takino; Y Okada; J Cao; A Shinagawa; E Yamamoto; M Seiki
Journal:  Nature       Date:  1994-07-07       Impact factor: 49.962

Review 7.  Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration.

Authors:  Guido W M Swart
Journal:  Eur J Cell Biol       Date:  2002-06       Impact factor: 4.492

8.  A proteomic approach for the elucidation of the specificity of ectodomain shedding.

Authors:  Kyoko Shirakabe; Yoshio Shibagaki; Akihiko Yoshimura; Shigeo Koyasu; Seisuke Hattori
Journal:  J Proteomics       Date:  2014-01-20       Impact factor: 4.044

9.  Mechanistic insights into ectodomain shedding: susceptibility of CADM1 adhesion molecule is determined by alternative splicing and O-glycosylation.

Authors:  Kyoko Shirakabe; Takuya Omura; Yoshio Shibagaki; Emiko Mihara; Keiichi Homma; Yukinari Kato; Akihiko Yoshimura; Yoshinori Murakami; Junichi Takagi; Seisuke Hattori; Yoshihiro Ogawa
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

Review 10.  Integrated functions of membrane-type 1 matrix metalloproteinase in regulating cancer malignancy: Beyond a proteinase.

Authors:  Takeharu Sakamoto; Motoharu Seiki
Journal:  Cancer Sci       Date:  2017-05-22       Impact factor: 6.716

View more
  4 in total

1.  To cut or not to cut: New rules for proteolytic shedding of membrane proteins.

Authors:  Stefan F Lichtenthaler; Edgar Meinl
Journal:  J Biol Chem       Date:  2020-08-28       Impact factor: 5.157

Review 2.  Intercellular signaling by ectodomain shedding at the synapse.

Authors:  M Dolores Martín-de-Saavedra; Marc Dos Santos; Peter Penzes
Journal:  Trends Neurosci       Date:  2022-04-13       Impact factor: 16.978

Review 3.  Strategies to Target ADAM17 in Disease: From its Discovery to the iRhom Revolution.

Authors:  Matteo Calligaris; Doretta Cuffaro; Simone Bonelli; Donatella Pia Spanò; Armando Rossello; Elisa Nuti; Simone Dario Scilabra
Journal:  Molecules       Date:  2021-02-10       Impact factor: 4.411

4.  ALCAM: A Novel Surface Marker on EpCAMlow Circulating Tumor Cells.

Authors:  Rossana Signorelli; Teresa Maidana Giret; Oliver Umland; Marco Hadisurya; Shweta Lavania; John Lalith Charles Richard; Ashley Middleton; Melinda Minucci Boone; Ayse Burcu Ergonul; Weiguo Andy Tao; Haleh Amirian; Anton Iliuk; Aliya Khan; Robert Diaz; Daniel Bilbao Cortes; Monica Garcia-Buitrago; Harrys Kishore Charles Jacob
Journal:  Biomedicines       Date:  2022-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.